Loading organizations...
Loading organizations...
Learn which startups First In Ventures invests in, what size check sizes they write, and who their partners are (e.g. Scott Roth).
Key people at First In Ventures.
First In Ventures is a venture capital firm specializing in early-stage security technology investments. It backs expert entrepreneurs developing innovative solutions across cybersecurity, dual-use/defense, and data intelligence. The firm provides strategic capital and operational support, accelerating growth for companies addressing critical national security and commercial challenges.
Founded in 2020 by Renny McPherson, Arthur Karell, and Lenore Karafa, First In Ventures leverages a deep understanding of the security sector. Managing Partner Renny McPherson, a former Marine Corps officer, and other team members apply extensive military and intelligence experience. This background enables the firm to identify and empower founders building crucial security innovations.
The firm supports mission-driven entrepreneurs advancing security technology. First In Ventures fosters the development of robust solutions for the future. Its vision is to cultivate a portfolio of companies that collectively enhance global security, making impactful investments that shape the cybersecurity and defense landscape.
Key people at First In Ventures.
First In Ventures is a U.S.-based venture capital firm specializing in early-stage investments primarily in the biotech and life sciences sectors, with a strong focus on seed and pre-seed rounds. The firm aims to support innovative startups by providing funding, mentorship, and resources to accelerate their growth and success. Additionally, there is a distinct entity named First In that focuses on early-stage security technology investments, backing entrepreneurs in cybersecurity, defense, and data sectors, particularly those with backgrounds in commercial, military, or intelligence security operations[1][2][3][4].
First In Ventures was founded around 2020 and is headquartered in Middletown, Delaware. It manages approximately $17 million in capital, targeting early-stage biotech and life sciences companies with check sizes typically ranging from $500,000 to $2 million. The firm’s founding partners bring operational expertise and a commitment to advancing healthcare innovation through strategic investments[3][5]. Separately, First In, the security-focused firm, was established by a team of founders and builders with operator experience in security, aiming to leverage their domain expertise to empower entrepreneurs securing critical infrastructure and freedom[2][5].
- First In (Security Technology):
First In Ventures taps into the growing demand for innovation in biotech and life sciences, sectors driven by advances in healthcare, agriculture, and research. Their early-stage focus helps bridge the funding gap for startups developing breakthrough therapies and technologies. Meanwhile, First In rides the critical trend of increasing cybersecurity needs amid rising global threats, defense modernization, and digital transformation. The timing is favorable as security technology becomes indispensable across commercial and government sectors, and biotech innovation continues to accelerate due to scientific advances and public health priorities[1][2][3].
Looking ahead, First In Ventures is well-positioned to capitalize on continued growth in biotech and life sciences, especially as personalized medicine, genomics, and agricultural biotech expand. Their ability to provide early capital and operational support will be key to nurturing disruptive startups. For First In, the security-focused firm, the future involves deepening investments in threat-led defense and operational intelligence platforms, sectors expected to grow with increasing cyber and physical security demands. Both firms’ influence will likely grow as they continue to back specialized entrepreneurs addressing critical challenges in health and security, reinforcing their roles as premier early-stage investors in their respective domains[2][5].
